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ABSTRACT
Objective Both excessive and insufﬁcient activation of
WNT signalling results in cartilage breakdown and
osteoarthritis. WNT16 is upregulated in the articular
cartilage following injury and in osteoarthritis. Here, we
investigate the function of WNT16 in osteoarthritis and
the downstream molecular mechanisms.
Methods Osteoarthritis was induced by destabilisation of
the medial meniscus in wild-type and WNT16-deﬁcient
mice. Molecular mechanisms and downstream effects were
studied in vitro and in vivo in primary cartilage progenitor
cells and primary chondrocytes. The pathway downstream
of WNT16 was studied in primary chondrocytes and using
the axis duplication assay in Xenopus.
Results WNT16-deﬁcient mice developed more severe
osteoarthritis with reduced expression of lubricin and
increased chondrocyte apoptosis. WNT16 supported the
phenotype of cartilage superﬁcial-zone progenitor cells and
lubricin expression. Increased osteoarthritis in WNT16-
deﬁcient mice was associated with excessive activation of
canonical WNT signalling. In vitro, high doses of WNT16
weakly activated canonical WNT signalling, but, in co-
stimulation experiments, WNT16 reduced the capacity of
WNT3a to activate the canonical WNT pathway. In vivo,
WNT16 rescued the WNT8-induced primary axis
duplication in Xenopus embryos.
Conclusions In osteoarthritis, WNT16 maintains a
balanced canonical WNT signalling and prevents
detrimental excessive activation, thereby supporting the
homeostasis of progenitor cells.
INTRODUCTION
Osteoarthritis (OA) is characterised by breakdown
of the articular cartilage, abnormal bone remodel-
ling, osteophytosis and, in some cases, low-degree
synovitis. It is a leading cause of chronic disability,
yet we still do not have a cure. Although generally
efﬁcacious, joint replacement does not live up to
patient expectation in up to 30% of cases,1 it has a
limited life span, often requiring complex revisions,
and is not suitable for the ever-growing population
of younger patients with early OA who have an
active lifestyle.
WNT signalling is involved in several biological
processes including joint formation during embry-
onic skeletogenesis and joint homeostasis and
disease in postnatal life.2–11
WNTs are a family of 19 highly conserved morpho-
gens that signal through several different pathways. In
the β-catenin-dependent (or canonical WNT)
pathway, engagement of WNTs with their receptors
results in the accumulation and nuclear translocation
of β-catenin and transcriptional activation of target
genes.12 The non-canonical pathways are less under-
stood and involve Ca2+ signalling, phosphatidylinosi-
tol-4,5-biphosphate 3-kinase (PI3K) and activation of
cjun N-terminal kinase (JNK).13
Although genetic studies in humans and experi-
mental studies in animals provide overwhelming evi-
dence for the role of WNT signalling in cartilage
homeostasis and OA, the mechanisms underpinning
these functions are still poorly understood. It has
been shown that a delicate balance of WNTactivity is
needed for cartilage homeostasis as both repression7
and constitutive activation8 of the β-catenin pathway
lead to cartilage breakdown. Similarly, excessive
WNT activation following loss of function of the
WNT inhibitor Frizzled related protein (FRZB)
resulted in increased susceptibility to OA in mice14
and in humans,15 but the excessive WNTsuppression
due to the tumour necrosis factor-dependent expres-
sion of DKK1 in inﬂammatory arthritis also results in
cartilage and bone destruction.16 17 How this balance
is achieved within the joint is unclear.
WNT16 is expressed in the joint interzones
during joint formation and in the superﬁcial cells
of the articular cartilage postnatally.4 5 In adult car-
tilage, it is not expressed in normal conditions, but
it is rapidly upregulated following injury or in OA.18
We demonstrate that WNT16 upregulation fol-
lowing injury protects cartilage from breakdown
following destabilisation of the medial meniscus
(DMM). This effect is likely mediated through upre-
gulation of lubricin, an essential joint lubricant that
protects chondrocytes from shear stresses and cartil-
age from mechanically induced breakdown.19 We
also show that WNT16 is a weak activator of canon-
ical WNT signalling in chondrocytes and that this is
required for the upregulation of lubricin. However,
in the presence of other more potent canonical
WNT ligands, WNT16 acts as an inhibitor, prevent-
ing excessive activation of the pathway, which is
known to result in cartilage damage.
METHODS
Surgical procedure
DMM was performed as previously described20 21
on 10-week-old male wnt16−/− or wild-type 129/Sv
mice (cousins). The contralateral knees were either
218 Nalesso G, et al. Ann Rheum Dis 2017;76:218–226. doi:10.1136/annrheumdis-2015-208577
Basic and translational research
group.bmj.com on July 31, 2017 - Published by http://ard.bmj.com/Downloaded from 
sham-operated or non-operated as an internal control. The mice
were sacriﬁced by cervical dislocation at 2 days, 7 days or
8 weeks post surgery.
Histological analysis and OA scoring
Histological processing was performed as discussed elsewhere21
and scored using the Osteoarthritis Research Society International
(OARSI) scoring system by two independent investigators.22 All
images were taken using the same settings on an Olympus BX61
microscope.
Immunohistochemistry and TUNEL staining
Immunohistochemistry and apoptosis detection were performed
as described in refs 21, 23, 24 and detailed in supplementary
materials.
Gene expression analysis
DMM or control joints were detached from the animals imme-
diately after death and the soft tissues removed under a dissect-
ing microscope. The articular surface of the femoral condyles
and the tibial plateaus was isolated at the level of the growth
plate using a scalpel and homogenised in 1 mL of Trizol (Life
Technologies).
In vitro gene expression analysis was performed on primary
human or bovine articular chondrocytes (BACs) obtained from
young animals (isolated as described in ref. 23) and on superﬁcial
zone cell (SZC) isolated from the knees of neonatal mice.5 Cells
were stimulated with WNT16, WNT3a or DKK1 recombinant
proteins (R&D Systems) for 24 h before phosphate buffered
saline (PBS) wash and addition of 1 mL of Trizol (Invitrogen) for
RNA isolation and Q-PCR analysis.23 A list of the primers used
can be found in online supplementary table S1.
SUPER8XTOPFlash reporter assay
The chondrocytes were co-transfected with SUPER8XTOPFlash
TCF/LEF-ﬁreﬂy luciferase reporter plasmid and CMV-Renilla
luciferase plasmid using JetPRIME transfection reagent
(Polyplus). The cells were stimulated for 48 h replacing the
medium after 24 h before luciferase activity was measured using
the Dual luciferase Reporter assay system (Promega).
Xenopus assay
Xenopus embryos were injected ventrally with either 0.02 ng/μL
wnt16 or 0.002 ng/μL wnt8 RNA at the four-cell stage and left
for 2 days to develop before analysis.
Statistical analysis
Parametric data were compared with the t test, non-parametric
data with the Wilcoxon–Mann–Whitney test. For multiple com-
parisons, the analysis of variance or Kruskal–Wallis test, includ-
ing the appropriate post test, was used. p Values <0.05 were
considered signiﬁcant: *p<0.05; **p<0.01; ***p<0.001.
RESULTS
WNT16 is transiently upregulated in cartilage following
DMM
We reported that the embryonic joint interzone marker WNT16
is re-expressed in the adult human articular cartilage following
acute injury and in OA.18
We ﬁrst conﬁrmed that WNT16 was no longer expressed in
healthy adult mouse articular cartilage, and that, following
DMM, it was upregulated at mRNA and protein level (ﬁgure 1).
Some upregulation also took place in sham-operated knees, par-
ticularly at early time points; however, DMM-operated knees
exhibited a greater upregulation at 7 days.
WNT16-deﬁcient mice have a more severe outcome
following surgical induction of OA
To elucidate the role of WNT16 upregulation following joint
injury, we generated WNT16 null mice (wnt16−/−) through
deletion of exon 2 by homologous recombination (see online
supplementary ﬁgure S1A). Successful recombination was
Figure 1 WNT16 is upregulated in experimental osteoarthritis induced by destabilisation of the medial meniscus (DMM). Wild-type mice received
DMM of the left knee and sham operation on the right and were killed at 2 days (C and D), 7 days (E and F) and 8 weeks (G) post surgery. (A)
WNT16 mRNA was upregulated in the whole joints of DMM-operated mice compared with sham-operated controls, reaching statistical signiﬁcance
after 7 days. WNT16 protein was undetectable in non-operated knees (B), but was upregulated at 2 days following DMM (C) and, to a lesser extent,
following sham operation (D). WNT16 expression was further increased in DMM-operated mice at 7 days (E) and to less of an extent following sham
operation (F) ( joint tissues labelled as follows: C, cartilage; B, subchondral bone; M, meniscus). After 8 weeks, (G) WNT16 was no longer detected
in DMM-operated knees. (H) Isotype negative control at the 2-day time point. N=3 per condition.
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conﬁrmed by PCR (see online supplementary ﬁgure S1B). The
mutants were backcrossed for nine generations in the 129/Sv
genetic background where no differences were detected in cartil-
age morphology (see online supplementary ﬁgure S1C,D). At
18 months of age, both wild-type and wnt16−/− animals devel-
oped minor superﬁcial cartilage irregularities in keeping with
the strain. In the 129/Sv genetic background, we did not detect
differences in bone structure/morphology as shown by
Micro-CT at the vertebral bodies (see online supplementary
ﬁgure S2) and the femoral epiphyses (see online supplementary
ﬁgure S3). The thickness of the subchondral bone was also com-
parable (see online supplementary ﬁgure S3C). However, in
keeping with a previous report,25 in the DBA/1 background,
spontaneous fractures occurred in wnt16−/− mice (not shown),
suggesting that the severity of the previously reported bone
phenotype is strain dependent. These results suggest that
WNT16 is not required for the normal development and
growth of synovial joints and, in resting conditions, the absence
of WNT16 does not predispose to OA.
Standard animal husbandry conditions are not always repre-
sentative of normal life, where, in humans, cartilage injuries are
common.26 Since WNT16 is upregulated in cartilage after
injury18 in humans and mice, we investigated whether the upre-
gulation of this molecule has a role in the adaptive responses
that restore cartilage homeostasis following injury. To study this,
we induced experimental OA in 10-week-old wnt16−/− and
wild-type controls (129/Sv background) by DMM.20
Eight weeks following DMM, wnt16−/− mice developed more
severe OA compared with wild-type controls as assessed by histo-
logical scoring22 27 (ﬁgure 2A, B) and histomorphometrical com-
parison of the intensity of safranin O staining (ﬁgure 2C). The
histomorphometry is described in online supplementary ﬁgure S4.
An independent experiment in mice at the ﬁfth backcross into the
129/Sv phenotype yielded similar results (data not shown). We did
not detect statistically signiﬁcant differences in the expression of
the aggrecanases ADAMTS-4/-5 or in the detection of aggrecan
neoepitopes generated by aggrecanase or matrix metalloproteases
(MMP) cleavage (see online supplementary ﬁgure S5).
These results suggest that WNT16 has a homeostatic role that
limits the extent of cartilage breakdown following induction of
joint instability.
WNT16-deﬁcient mice fail to upregulate the joint lubricant
lubricin, following surgical induction of OA
WNT signalling is essential for the expression of the joint lubri-
cant lubricin.5 Deﬁciency of Prg4 (gene encoding for lubricin)
in mice and loss of function mutations in humans leads to cartil-
age breakdown and spontaneous OA due to increased coefﬁcient
of friction in the joint.19 Wnt16−/− and wild-type mice showed
similar levels of lubricin under resting conditions; however,
2 days following surgery, wild-type mice, but not wnt16−/−,
upregulated lubricin expression at mRNA and protein level
(ﬁgure 3A–C).
Figure 2 Wnt16−/− mice are more susceptible to instability-induced osteoarthritis. The 10-week-old mice (7 wild-type (WT) and 10 wnt16−/− (KO))
were subjected to destabilisation of the medial meniscus and the outcome was compared 8 weeks following surgery. (A) Safranin O staining of the
medial compartment of representative sections. (B) OARSI histological score. (C) Intensity of the safranin O in the medial tibial plateau. LF, lateral
femur; LT, lateral tibia; MF, medial femur; MT, medial tibia.
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Treatment of primary BACs with recombinant WNT16 was
sufﬁcient to upregulate lubricin expression in vitro (ﬁgure 3D).
Loss of WNT16 resulted in increased apoptosis in the SZCs
of the articular cartilage
Spontaneous OA development in Prg4-deﬁcient mice is associated
with chondrocyte apoptosis.19 Two days following DMM, when
WNT16 is upregulated in wild-type mice, WNT16-deﬁcient mice
developed increased apoptosis. This selectively occurred in the
superﬁcial layer of the cartilage and, as expected, was particularly
increased in the medial compartment of the knee where the
osteoarthritic lesions are most severe (ﬁgure 4A, B).
As the loss of WNT16 speciﬁcally affected apoptosis in the
SZCs and as these cells speciﬁcally express WNT16 during
embryonic and early postnatal development, we explored the
effect of WNT16 in the SZC. In adulthood, these cells are con-
sidered a speciﬁc progenitor cell population within the
permanent articular cartilage and are essential for cartilage
homeostasis.28 Cells were isolated as previously described from
the knees of neonatal mice.5 These cells display a marker proﬁle
characterised by expression of WNT16 and lubricin, and low
expression of COL2A1, Aggrecan and Matrilin15 6 (see online
supplementary ﬁgure S6). The remainder of the neonatal
epiphysis is prevalently composed of epiphysial chondrocytes
that are destined to be replaced by bone, do not express
WNT16 and do express Matrilin1.29
In cultures enriched for SZC from wnt16−/− mice, recom-
binant WNT16 upregulated the SZC lineage marker lubricin,
downregulated the epiphysial lineage marker Matrilin1 and
inhibited the expression of SOX9, which is expressed at
higher level in epiphysial chondrocytes compared with SZC
(ﬁgure 4C).5 This suggested that rather than just upregulating
lubricin, WNT16 speciﬁcally supports the phenotype marker
proﬁle of the SZC.
Figure 3 Lubricin was upregulated following destabilisation of the medial meniscus (DMM). Wild-type (WT) and wnt16−/− mice were subjected to
DMM and killed 2 days thereafter. (A) The joint surface, including the articular cartilage and the subchondral bone, was dissected and processed for
gene expression analysis by real-time PCR. Lubricin was upregulated in WT mice but not in wnt16−/− mutants at mRNA level 2 days following DMM
(N≥10). (B) At protein level, lubricin staining following DMM was detected in the superﬁcial layer of the articular cartilage and in a region between
the intermediate and the deep layer in WT mice. (C) The area of the articular cartilage positive for lubricin staining 2 days following DMM was
signiﬁcantly higher in WT mice (N=4) than in wnt16−/− mice (N=6). (D) WNT16 recombinant protein upregulated lubricin mRNA expression in
bovine articular chondrocyte (BAC) at 24 h (N=3). KO, knockout. *p<0.05; **p<0.01; ***p<0.001.
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WNT16 maintains a balanced activation of the canonical
pathway
Since canonical WNT signalling supports the phenotype of the
superﬁcial zone chondrocytes,5 6 we tested whether WNT16
could activate the canonical WNT pathway in chondrocytes and
whether canonical WNT activation was required for lubricin
upregulation by WNT16. In keeping with previous reports,3 25
WNT16 concentrations of 200 ng/mL or higher consistently
and dose-dependently upregulated Axin2 (a transcriptional
target of canonical signalling) in primary human and BACs
(ﬁgure 5A and online supplementary ﬁgure S7A).
Interestingly, although WNT16 was not as efﬁcient as
WNT3a at activating the canonical pathway, it caused a larger
upregulation of lubricin (ﬁgure 5B, C and online supplementary
ﬁgure S7B), which still was partially abolished by the canonical
WNT inhibitor DKK1 (ﬁgure 5C and online supplementary
ﬁgure S7C).
Since WNT16 could activate the canonical WNT pathway in
vitro, we expected that wnt16−/− mice would display decreased
Axin2 upregulation following experimental OA. Surprisingly,
WNT16-deﬁcient mice had higher levels of Axin2, indicating a
higher level of canonical pathway activation (ﬁgure 5D). Since
WNT16 is a weak activator of the canonical pathway (ﬁgure 5A),
we hypothesised that, in vivo, WNT16 could compete with
other, more potent, WNTs activated in OA,14 thereby limiting
their capacity to disproportionately activate the β-catenin
pathway, which is known to result in further cartilage break-
down. To conﬁrm this hypothesis, we investigated whether
Figure 4 Disruption of WNT16 results in apoptosis of superﬁcial cartilage cells and in the loss of superﬁcial zone molecular markers. Terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining of representative sections from the medial compartment of the knee of
wild-type (WT) and wnt16−/− mice 2 days after destabilisation of the medial meniscus (DMM) (N=6) (A). The TUNEL staining (shown in red) was
superimposed on the Nomarski image for anatomical orientation. Quantiﬁcation of TUNEL-positive cells in the superﬁcial and deep layers of the
articular cartilage within the medial compartment (most affected in DMM) and lateral compartment (mildly or unaffected) (B). Gene expression
analysis of superﬁcial zone cells from wnt16−/− mice with or without rescue with exogenous 200 ng/mL recombinant WNT16 (N=4) (C). KO,
knockout. *p<0.05.
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WNT16 could stunt the WNT3a-induced activation of the
canonical pathway. As expected, WNT3a alone dose-
dependently activated the SUPER8XTOPFLASH reporter assay
(ﬁgure 5E), but co-treatment with WNT16 dose-dependently
inhibited the WNT3a-induced reporter activity starting from
concentrations as low as 50 ng/mL (ﬁgure 5E, F).
To investigate whether WNT16 can inhibit the signalling of
more potent canonical WNTs in vivo and in different bio-
logical contexts, we used the well-established Xenopus assay
where injection of a ventral blastomere at the four-cell stage
with WNT ligands that activate the canonical WNT pathway
induces complete primary axis duplication or a strong
hyperdorsalisation.30
As expected, injection of wnt8 induced complete axis duplica-
tion in the majority of the tadpoles, as deﬁned by complete dupli-
cation of the cement gland (yellow arrowhead) (ﬁgure 5G, H).
Consistent with our data, injection of wnt16 RNA mostly induced
weak hyperdorsalisation, which indicates a very mild activation of
the β-catenin pathway. However, co-injection of wnt16 and wnt8
resulted in inhibition of the complete axis duplication induced by
wnt8 and in a phenotype resembling that induced by the injection
of wnt16 alone (ﬁgure 5G, H).
We propose a model where WNT16 buffers the activation of
the canonical WNT pathway, overcoming the activity of more
potent canonical WNT ligands such as WNT3a and wnt8, and
supporting a controlled mild activation of WNT signalling,
Figure 5 WNT16 is a weak activator of the β-catenin-dependent pathway but also limits its activation by other more potent canonical WNTs.
WNT16 caused a weak upregulation of the canonical WNT reporter gene Axin2 compared with WNT3a, in human articular chondrocytes (HAC) (N=3
patients, 4 replicates each) (A). Lubricin expression caused by WNT16 stimulation (ng/mL) in HAC (B), and mouse superﬁcial zone cell (SZC) (C), was
higher than that caused by WNT3a stimulation. Lubricin expression decreased in the presence of canonical inhibitor DKK1 (100 ng/mL) in mouse SZC
(N=4) (C). All at 24 h. Following destabilisation of the medial meniscus (DMM) surgery, wnt16−/− mice had a higher expression of Axin2 mRNA in
their joints (D). WNT16 reduced the capacity of WNT3a to activate the SUPER8XTOPFlash reporter assay in HEK293 cells treated with WNT3a, alone
and in combination with WNT16 (ng/mL) (N=4) (E and F). wnt16 inhibited axis duplication caused by wnt8 in Xenopus laevis (G and H). Embryos
were injected ventrally with 0.02 ng/mL wnt16 or 0.002 ng/mL wnt8 at the four-cell stage and left for 2 days to develop (n=36–47).
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while preventing the excessive activation mediated by other
WNTs (ﬁgure 6).
DISCUSSION
We discovered that, whereas WNT16 is dispensable during joint
embryonic morphogenesis, when other Wnts (WNT9a and
WNT4) are also expressed within the joint interzones, its upre-
gulation following injury in adult life is essential to preserve car-
tilage homeostasis. This likely occurs through the unique
capacity of this WNT ligand to prevent excessive activation of
the canonical WNT pathway by limiting the capacity of other
more potent WNT ligands and by contributing to the upregula-
tion of lubricin, an essential joint lubricant that protects chon-
drocytes from shear stress. Through activation of the canonical
WNT pathway, WNT16 was a speciﬁc activator of lubricin since
WNT3a was more potent in activating the canonical WNT
pathway but far less potent in upregulating lubricin.
Recently, it was reported that WNT16 produced by osteo-
blasts supports cortical bone formation and bone homeostasis
by inhibiting osteoclastogenesis.25 Mutants lacking either exons
2 and 3 or the entire open-reading frame of wnt16 gene dis-
played the same phenotype.25 We originally backcrossed our
mutants in the DBA/1 genetic background and also observed a
high incidence of spontaneous fractures as described.25
However, this was not observed in the 129/Sv genetic back-
ground, hence OA was induced in the 129/Sv background. It
would have been interesting to investigate whether in the DBA/1
the OA phenotype was more severe due to the underlying bone
phenotype. However, the lack of load on the knee due to the
tibial fracture would have been a confounding element.
OA is a disease of the whole joint, and, in particular, the car-
tilage and bone form a functional unit that shares cellular and
molecular homeostatic mechanisms.31 It is interesting to note
how loss of function of the WNT inhibitor FRZB was also asso-
ciated with increased susceptibility to OA in mice14 and
humans,15 but as opposed to WNT16-deﬁcient mice, also with
increased bone mass.14 These data stress the importance of the
interplay of the cartilage and bone functional unit in OA devel-
opment.31 Compared with FRZB, WNT16 has some agonist
activity and this may explain the opposite phenotype in the
bone. It would be interesting to understand the possible redun-
dancies and the contribution of this agonistic activity in the
context of joint homeostasis and the respective contribution of
these two molecules.
Conditional WNT16 knockout (KO) in cartilage or bone will
represent an opportunity to understand the speciﬁc roles of
WNT16 and of these two tissues in the development of OA.
The fact that, following acute cartilage injury, FRZB is down-
regulated and WNT16 is upregulated suggests that this differ-
ence may play an important role following injury. It would be
interesting to understand the possible redundancies and the con-
tribution of this agonistic activity in the context of joint homeo-
stasis and the respective contribution of these two molecules.
Lubricin is essential for joint homeostasis and its disruption
results in cartilage breakdown associated with chondrocyte
apoptosis, which was also seen in our model and was restricted
to the superﬁcial region of the articular cartilage. However, we
also noticed that exogenous WNT16 modulated other markers
of the SZCs, which produce lubricin. Recent data support the
concept that SZCs represent speciﬁc progenitor cells in the
articular cartilage5 6 and that they are mobilised to the site of
cartilage damage following injury.32 It is therefore possible that
the increased susceptibility to OA of WNT16-deﬁcient mice
might be caused not just by the failure to upregulate lubricin fol-
lowing DMM, but by a more general phenotypic derangement
of the SZCs, as suggested by the alteration in the expression of
multiple markers when stimulated with WNT16. This likely
occurs as a result of loss of controlled canonical WNT signalling
as in development, the differentiation and maintenance of such
important cell population is highly dependent on the mainten-
ance of a balanced activation of canonical WNT signalling at the
cartilage surface.3–8
Figure 6 Cartilage injury causes activation of WNT signalling through downregulation of antagonists such as FRZB and upregulation of several
agonists such as WNT16 and WNT8.14 18 WNT16 buffers the canonical WNT activation to homeostatic levels through its capacity to directly support
a weak activation and preventing excessive activation induced by other ligands. Excessive canonical WNT activation causes cartilage breakdown by
driving inappropriate maturation particularly within the superﬁcial zone progenitor cells,8 18 whereas homeostatic levels of activation are necessary
for supporting the superﬁcial progenitor population and lubricin expression (this work and refs 5, 7).
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The modulation of canonical WNT signalling by WNT16 is
likely the most important element of novelty in this study.
Movérare-Skrtic et al25 reported that WNT16 is a weak agonist
of the canonical WNT signalling. Here, we conﬁrmed these data
and add that it also functions as an inhibitor when administered
together with more potent WNT proteins. Both excessive acti-
vation8 14 15 or excessive suppression6 7 16 17 of WNT signalling
causes cartilage loss in mice as well as in humans. Therefore,
after injury, WNT16 may trigger controlled homeostatic
responses, which, in the early phases of OA, have a chance to
halt cartilage loss and ensure that the net activation of WNT sig-
nalling is sustained so as to allow maintenance of chondrogenic
stem cells4–6 but without exceeding the limits that would cause
cartilage breakdown. This modality of signalling was not limited
to the articular cartilage and OA but was extended to biological
contexts as remote as Xenopus development. It is therefore
likely that WNT16 may represent a ‘buffering WNT’ in several
other contexts when WNT activation is desirable but excessive
activation is not, such as in skin wound healing,33–37 and pro-
vides an explanation of how a ﬁne balance of WNTactivation is
achieved in highly dynamic biological contexts such as repair
and homeostasis.
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